NIPH Clinical Trials Search

JAPANESE
UMIN ID: UMIN000061973

Registered date:20/06/2026

Prospective feasibility study of HYBRIDknifeflex-assisted gastric ESD using Gas-free Immersion and Flow-Assisted Coagulation

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiedGastric adenoma and early gastric cancer indicated for endoscopic submucosal dissection (ESD)
Date of first enrollment2026/06/22
Target sample size50
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Gastric ESD will be performed using HYBRIDknifeflex under the Gas-free Immersion (GFI) system. Flow-Assisted Coagulation (FAC) will be used for prophylactic coagulation and hemostasis when appropriate. The study prospectively evaluates the feasibility, safety, and procedural efficiency of this strategy.

Outcome(s)

Primary OutcomeDissection speed (mm2min)
Secondary Outcome1. Procedure time 2. Resection time 3. Injection time 4. Hemostasis time 5. Number of intraoperative bleeding events 6. Total bleeding duration 7. Volume of injection solution 8. Number of hemostatic forceps uses 9. En bloc resection rate 10. R0 resection rate 11. Intraoperative perforation 12. Delayed bleeding 13. PECS 14. Aspiration pneumonia

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum100years-old
GenderMale and Female
Include criteria1. Patients aged 20 to 100 years. 2. Patients with gastric adenoma, early gastric cancer, or gastric epithelial neoplasms suspected of early gastric cancer. 3. Patients judged to be indicated for gastric ESD according to clinical practice and relevant guidelines. 4. Patients scheduled to undergo gastric ESD during hospitalization. 5. Patients who provide written informed consent.
Exclude criteria1. Patients for whom surgical treatment is considered more appropriate. 2. Patients with severe comorbidities precluding safe endoscopic treatment or sedation. 3. Patients with severe coagulation disorders or other conditions that make ESD unsafe. 4. Pregnant women or patients suspected of being pregnant. 5. Patients judged inappropriate for participation by the investigators.

Related Information

Contact

public contact
Name Tatsuma Nomura
Address Suzuka General Hospital, 1275-53, Yamanohana, Yasuduka, suzuka, Mie Japan 510-0235
Telephone 0593821311
E-mail m06076tn@icloud.com
Affiliation Suzuka General Hospital Department of Gastroenterology
scientific contact
Name Tatsuma Nomura
Address Suzuka General Hospital, 1275-53, Yamanohana, Yasuduka, suzuka, Mie Japan
Telephone 09064948705
E-mail m06076tn@icloud.com
Affiliation Suzuka General Hospital Department of Gastroenterology